desacetylnantradol has been researched along with raloxifene hydrochloride in 1 studies
Studies (desacetylnantradol) | Trials (desacetylnantradol) | Recent Studies (post-2010) (desacetylnantradol) | Studies (raloxifene hydrochloride) | Trials (raloxifene hydrochloride) | Recent Studies (post-2010) (raloxifene hydrochloride) |
---|---|---|---|---|---|
18 | 0 | 0 | 2,818 | 481 | 810 |
Protein | Taxonomy | desacetylnantradol (IC50) | raloxifene hydrochloride (IC50) |
---|---|---|---|
Estrogen receptor | Homo sapiens (human) | 0.0053 | |
Gastric inhibitory polypeptide receptor | Homo sapiens (human) | 0.0004 | |
Estrogen receptor beta | Homo sapiens (human) | 0.1297 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Howlett, AC; Ruh, MF; Taylor, JA; Welshons, WV | 1 |
1 other study(ies) available for desacetylnantradol and raloxifene hydrochloride
Article | Year |
---|---|
Failure of cannabinoid compounds to stimulate estrogen receptors.
Topics: Breast Neoplasms; Cannabinoids; Cell Division; Dronabinol; Estrogens; Humans; Phenanthridines; Piperidines; Raloxifene Hydrochloride; Receptors, Estrogen; Transcriptional Activation; Tumor Cells, Cultured | 1997 |